A microfluidic Transwell to study chemotaxis

Chentian Zhang, Maria P. Barrios, Rhoda M. Alani, Mario Cabodi, Joyce Y. Wong

Research output: Contribution to journalArticle

Abstract

Chemotaxis is typically studied in vitro using commercially available products such as the Transwell® in which cells migrate through a porous membrane in response to one or more clearly defined chemotactic stimuli. Despite its widespread use, the Transwell assay suffers from being largely an endpoint assay, with built-in errors due to inconsistent pore size and human sampling. In this study, we report a microfluidic chemotactic chip that provides real-time monitoring, consistent paths for cell migration, and easy on-chip staining for quantifying migration. To compare its performance with that of a traditional Transwell chamber, we investigate the chemotactic response of MDA-MB-231 1833 metastatic breast cancer cells to epidermal growth factor (EGF). The results show that while both platforms were able to detect a chemotactic response, we observed a dose-dependent response of breast cancer cells towards EGF with low non-specific migration using the microfluidic platform, whereas we observed a dose-independent response of breast cancer cells towards EGF with high levels of non-specific migration using the commercially available Transwell.The microfluidic platform also allowed EGF-dependent chemotactic responses to be observed 24 h, a substantially longer window than seen with the Transwell. Thus the performance of our microfluidic platform revealed phenomena that were not detected in the Transwell under the conditions tested.

Original languageEnglish (US)
Pages (from-to)159-165
Number of pages7
JournalExperimental Cell Research
Volume342
Issue number2
DOIs
StatePublished - Mar 15 2016
Externally publishedYes

Fingerprint

Microfluidics
Chemotaxis
Epidermal Growth Factor
Breast Neoplasms
Endpoint Determination
Cell Movement
Staining and Labeling
Membranes

Keywords

  • Breast cancer
  • Cell migration
  • Chemotaxis
  • EGF
  • Microfluidics
  • Transwell

ASJC Scopus subject areas

  • Cell Biology

Cite this

Zhang, C., Barrios, M. P., Alani, R. M., Cabodi, M., & Wong, J. Y. (2016). A microfluidic Transwell to study chemotaxis. Experimental Cell Research, 342(2), 159-165. https://doi.org/10.1016/j.yexcr.2016.03.010

A microfluidic Transwell to study chemotaxis. / Zhang, Chentian; Barrios, Maria P.; Alani, Rhoda M.; Cabodi, Mario; Wong, Joyce Y.

In: Experimental Cell Research, Vol. 342, No. 2, 15.03.2016, p. 159-165.

Research output: Contribution to journalArticle

Zhang, C, Barrios, MP, Alani, RM, Cabodi, M & Wong, JY 2016, 'A microfluidic Transwell to study chemotaxis', Experimental Cell Research, vol. 342, no. 2, pp. 159-165. https://doi.org/10.1016/j.yexcr.2016.03.010
Zhang C, Barrios MP, Alani RM, Cabodi M, Wong JY. A microfluidic Transwell to study chemotaxis. Experimental Cell Research. 2016 Mar 15;342(2):159-165. https://doi.org/10.1016/j.yexcr.2016.03.010
Zhang, Chentian ; Barrios, Maria P. ; Alani, Rhoda M. ; Cabodi, Mario ; Wong, Joyce Y. / A microfluidic Transwell to study chemotaxis. In: Experimental Cell Research. 2016 ; Vol. 342, No. 2. pp. 159-165.
@article{05ad3da908f44c8891396b4cdd6f4983,
title = "A microfluidic Transwell to study chemotaxis",
abstract = "Chemotaxis is typically studied in vitro using commercially available products such as the Transwell{\circledR} in which cells migrate through a porous membrane in response to one or more clearly defined chemotactic stimuli. Despite its widespread use, the Transwell assay suffers from being largely an endpoint assay, with built-in errors due to inconsistent pore size and human sampling. In this study, we report a microfluidic chemotactic chip that provides real-time monitoring, consistent paths for cell migration, and easy on-chip staining for quantifying migration. To compare its performance with that of a traditional Transwell chamber, we investigate the chemotactic response of MDA-MB-231 1833 metastatic breast cancer cells to epidermal growth factor (EGF). The results show that while both platforms were able to detect a chemotactic response, we observed a dose-dependent response of breast cancer cells towards EGF with low non-specific migration using the microfluidic platform, whereas we observed a dose-independent response of breast cancer cells towards EGF with high levels of non-specific migration using the commercially available Transwell.The microfluidic platform also allowed EGF-dependent chemotactic responses to be observed 24 h, a substantially longer window than seen with the Transwell. Thus the performance of our microfluidic platform revealed phenomena that were not detected in the Transwell under the conditions tested.",
keywords = "Breast cancer, Cell migration, Chemotaxis, EGF, Microfluidics, Transwell",
author = "Chentian Zhang and Barrios, {Maria P.} and Alani, {Rhoda M.} and Mario Cabodi and Wong, {Joyce Y.}",
year = "2016",
month = "3",
day = "15",
doi = "10.1016/j.yexcr.2016.03.010",
language = "English (US)",
volume = "342",
pages = "159--165",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - A microfluidic Transwell to study chemotaxis

AU - Zhang, Chentian

AU - Barrios, Maria P.

AU - Alani, Rhoda M.

AU - Cabodi, Mario

AU - Wong, Joyce Y.

PY - 2016/3/15

Y1 - 2016/3/15

N2 - Chemotaxis is typically studied in vitro using commercially available products such as the Transwell® in which cells migrate through a porous membrane in response to one or more clearly defined chemotactic stimuli. Despite its widespread use, the Transwell assay suffers from being largely an endpoint assay, with built-in errors due to inconsistent pore size and human sampling. In this study, we report a microfluidic chemotactic chip that provides real-time monitoring, consistent paths for cell migration, and easy on-chip staining for quantifying migration. To compare its performance with that of a traditional Transwell chamber, we investigate the chemotactic response of MDA-MB-231 1833 metastatic breast cancer cells to epidermal growth factor (EGF). The results show that while both platforms were able to detect a chemotactic response, we observed a dose-dependent response of breast cancer cells towards EGF with low non-specific migration using the microfluidic platform, whereas we observed a dose-independent response of breast cancer cells towards EGF with high levels of non-specific migration using the commercially available Transwell.The microfluidic platform also allowed EGF-dependent chemotactic responses to be observed 24 h, a substantially longer window than seen with the Transwell. Thus the performance of our microfluidic platform revealed phenomena that were not detected in the Transwell under the conditions tested.

AB - Chemotaxis is typically studied in vitro using commercially available products such as the Transwell® in which cells migrate through a porous membrane in response to one or more clearly defined chemotactic stimuli. Despite its widespread use, the Transwell assay suffers from being largely an endpoint assay, with built-in errors due to inconsistent pore size and human sampling. In this study, we report a microfluidic chemotactic chip that provides real-time monitoring, consistent paths for cell migration, and easy on-chip staining for quantifying migration. To compare its performance with that of a traditional Transwell chamber, we investigate the chemotactic response of MDA-MB-231 1833 metastatic breast cancer cells to epidermal growth factor (EGF). The results show that while both platforms were able to detect a chemotactic response, we observed a dose-dependent response of breast cancer cells towards EGF with low non-specific migration using the microfluidic platform, whereas we observed a dose-independent response of breast cancer cells towards EGF with high levels of non-specific migration using the commercially available Transwell.The microfluidic platform also allowed EGF-dependent chemotactic responses to be observed 24 h, a substantially longer window than seen with the Transwell. Thus the performance of our microfluidic platform revealed phenomena that were not detected in the Transwell under the conditions tested.

KW - Breast cancer

KW - Cell migration

KW - Chemotaxis

KW - EGF

KW - Microfluidics

KW - Transwell

UR - http://www.scopus.com/inward/record.url?scp=84962228225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962228225&partnerID=8YFLogxK

U2 - 10.1016/j.yexcr.2016.03.010

DO - 10.1016/j.yexcr.2016.03.010

M3 - Article

C2 - 26988422

AN - SCOPUS:84962228225

VL - 342

SP - 159

EP - 165

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 2

ER -